Defined Financial Planning LLC Sells 552 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Defined Financial Planning LLC reduced its holdings in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 51.3% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 524 shares of the healthcare conglomerate’s stock after selling 552 shares during the quarter. Defined Financial Planning LLC’s holdings in UnitedHealth Group were worth $274,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Waycross Partners LLC increased its stake in shares of UnitedHealth Group by 2.4% in the 4th quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate’s stock valued at $14,060,000 after buying an additional 658 shares during the period. Sherbrooke Park Advisers LLC acquired a new stake in UnitedHealth Group during the 4th quarter worth $515,000. Full Sail Capital LLC increased its stake in UnitedHealth Group by 2.1% during the 4th quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate’s stock worth $815,000 after purchasing an additional 33 shares in the last quarter. Soros Fund Management LLC bought a new position in UnitedHealth Group during the 4th quarter worth about $39,413,000. Finally, Silvercrest Asset Management Group LLC grew its holdings in shares of UnitedHealth Group by 47.8% during the fourth quarter. Silvercrest Asset Management Group LLC now owns 38,796 shares of the healthcare conglomerate’s stock worth $19,625,000 after buying an additional 12,550 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Kristen Gil acquired 3,700 shares of the company’s stock in a transaction that occurred on Thursday, May 15th. The stock was bought at an average price of $271.17 per share, with a total value of $1,003,329.00. Following the purchase, the director now owns 3,818 shares in the company, valued at approximately $1,035,327.06. The trade was a 3,135.59% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director John H. Noseworthy purchased 300 shares of UnitedHealth Group stock in a transaction dated Wednesday, May 14th. The shares were bought at an average price of $312.16 per share, for a total transaction of $93,648.00. Following the acquisition, the director now owns 6,063 shares in the company, valued at approximately $1,892,626.08. This trade represents a 5.21% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last quarter, insiders bought 109,408 shares of company stock valued at $31,607,768. Corporate insiders own 0.28% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UNH stock opened at $310.70 on Thursday. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73. The company has a market capitalization of $281.85 billion, a P/E ratio of 20.05, a P/E/G ratio of 1.37 and a beta of 0.45. The company’s 50-day simple moving average is $395.60 and its two-hundred day simple moving average is $478.20. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNHGet Free Report) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). The firm had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same quarter last year, the business earned $6.91 earnings per share. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th will be given a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 2.85%. The ex-dividend date is Monday, June 16th. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.10. UnitedHealth Group’s dividend payout ratio is currently 37.02%.

Analysts Set New Price Targets

Several equities research analysts have commented on the stock. Wolfe Research cut their price target on shares of UnitedHealth Group from $501.00 to $390.00 and set an “outperform” rating on the stock in a research report on Tuesday, May 20th. Bank of America cut shares of UnitedHealth Group from a “buy” rating to a “neutral” rating and lowered their price target for the company from $560.00 to $350.00 in a report on Wednesday, May 14th. Robert W. Baird cut UnitedHealth Group from an “outperform” rating to a “neutral” rating and set a $312.00 price objective on the stock. in a research report on Wednesday. Morgan Stanley lowered their target price on shares of UnitedHealth Group from $563.00 to $374.00 and set an “overweight” rating on the stock in a report on Wednesday, May 14th. Finally, Erste Group Bank cut shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, April 30th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have assigned a buy rating to the stock. According to data from MarketBeat, UnitedHealth Group currently has an average rating of “Moderate Buy” and an average price target of $426.52.

Check Out Our Latest Stock Analysis on UnitedHealth Group

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read More

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.